GXLV.L vs. BTEE.L
Compare and contrast key facts about SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L).
GXLV.L and BTEE.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GXLV.L is a passively managed fund by State Street that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Jul 7, 2015. BTEE.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Mar 5, 2018. Both GXLV.L and BTEE.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
GXLV.L vs. BTEE.L - Performance Comparison
Loading graphics...
GXLV.L vs. BTEE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | -3.43% | 7.08% | 3.59% | -3.78% | 7.82% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.34% | 23.36% | 0.03% | 0.55% | 4.73% |
Different Trading Currencies
GXLV.L is traded in GBP, while BTEE.L is traded in USD. To make them comparable, the BTEE.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, GXLV.L achieves a -3.43% return, which is significantly lower than BTEE.L's 4.34% return.
GXLV.L
- 1D
- 7,436.27%
- 1M
- -4.37%
- YTD
- -3.43%
- 6M
- 5.44%
- 1Y
- 1.81%
- 3Y*
- 3.98%
- 5Y*
- —
- 10Y*
- —
BTEE.L
- 1D
- -0.24%
- 1M
- 0.96%
- YTD
- 4.34%
- 6M
- 18.75%
- 1Y
- 36.91%
- 3Y*
- 10.36%
- 5Y*
- 5.38%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GXLV.L vs. BTEE.L - Expense Ratio Comparison
GXLV.L has a 0.15% expense ratio, which is lower than BTEE.L's 0.35% expense ratio.
Return for Risk
GXLV.L vs. BTEE.L — Risk / Return Rank
GXLV.L
BTEE.L
GXLV.L vs. BTEE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GXLV.L | BTEE.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.00 | 1.68 | -1.68 |
Sortino ratioReturn per unit of downside risk | 75.07 | 2.26 | +72.81 |
Omega ratioGain probability vs. loss probability | 38.79 | 1.30 | +37.50 |
Calmar ratioReturn relative to maximum drawdown | -0.02 | 4.38 | -4.40 |
Martin ratioReturn relative to average drawdown | -0.18 | 14.45 | -14.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GXLV.L | BTEE.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.00 | 1.68 | -1.68 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.26 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | 0.33 | -0.32 |
Correlation
The correlation between GXLV.L and BTEE.L is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
GXLV.L vs. BTEE.L - Dividend Comparison
GXLV.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.37%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.37% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
Drawdowns
GXLV.L vs. BTEE.L - Drawdown Comparison
The maximum GXLV.L drawdown since its inception was -98.76%, which is greater than BTEE.L's maximum drawdown of -30.88%. Use the drawdown chart below to compare losses from any high point for GXLV.L and BTEE.L.
Loading graphics...
Drawdown Indicators
| GXLV.L | BTEE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.76% | -38.29% | -60.47% |
Max Drawdown (1Y)Largest decline over 1 year | -98.76% | -12.65% | -86.11% |
Max Drawdown (5Y)Largest decline over 5 years | — | -38.29% | — |
Current DrawdownCurrent decline from peak | -6.45% | -3.52% | -2.93% |
Average DrawdownAverage peak-to-trough decline | -7.00% | -13.77% | +6.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.32% | 2.59% | +8.73% |
Volatility
GXLV.L vs. BTEE.L - Volatility Comparison
SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) has a higher volatility of 625.51% compared to iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) at 7.08%. This indicates that GXLV.L's price experiences larger fluctuations and is considered to be riskier than BTEE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GXLV.L | BTEE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 625.51% | 7.08% | +618.43% |
Volatility (6M)Calculated over the trailing 6-month period | 612.93% | 14.13% | +598.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 7,542.84% | 21.91% | +7,520.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 5,108.99% | 20.77% | +5,088.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 5,108.99% | 22.43% | +5,086.56% |